The NHS 10-Year Plan: Strategic Vision or Delivery Dilemma?

After working through all ten chapters of the NHS 10-Year Plan, one thing is clear, this is a plan with vision.

It offers a compelling picture of a more integrated, preventive, community based NHS, rooted in neighbourhood teams, powered by data and innovation and focused on population health and outcomes.

But it’s also a plan that asks a lot with little on offer in return, at least in the short term. No new money. No clear timescales. No detailed delivery roadmap. And growing concern from those on the ground that this might be less of a partnership and more of a directive.

After reading, digesting and listening to clinicians, commissioners and industry partners, here’s my take on what the plan really means and what pharma, medtech and device companies need to keep a close eye on.

Five Strengths of the NHS 10-Year Plan Suppliers Shouldn’t Ignore

To be fair, there is a great deal to welcome in the plan:

• The left shift is now unambiguous. Care is moving out of hospital and into the community. Not as a pilot but as policy.
• Integrated Neighbourhood Teams (INTs) are positioned as the future core of delivery.
• Prevention, population health, digital and data sit front and centre.
• Two new GP contract models reflect a serious rethink of how General Practice operates.
• Research and innovation are no longer bolt-ons, they’re clear system priorities.

This is not incremental reform. It’s a proposed reset of the NHS operating model.

Where The NHS Plan Falls Short, and Why It Matters for Delivery

Despite that ambition, the plan falls short in some critical ways:

• There is no new money to support transformation. Nothing for workforce, digital, premises or double running services during transition.
• There are no clear timelines or deadlines. Transformation without timescales becomes optional, and patchy.
• Accountability remains soft. It’s not always clear who funds what, who delivers what, or what happens if systems don’t meet expectations.

I’ve been saying for years that you cannot move services from hospitals into the community without first building the capacity to receive them. That takes investment, both capital and revenue. Right now, local systems are being asked to do more, differently, with less.

General Practice in the Crosshairs: Partnership, Power Shift Or Soft Squeeze?

The plan gives GPs a choice to remain in the partnership model or adopt one of two new contract options to lead INTs. In theory, this allows flexibility. But in practice, many GPs feel it’s a soft squeeze toward integration, with consequences for those who stay outside.

Clients have already shared concerns that opting out may mean losing access to Local Enhanced Services or investment flows, eventually referring patients into INTs rather than leading care. And once an INT is formed, those outside may lose their voice in shaping it.

This is not just operational, it’s existential. As one GP put it: “We’ll be starved into joining, but by then, the model will be imposed, not co-designed.”

The Missing Link: Why Workforce Realism Must Precede Reform

The plan reaffirms the 2023 Long Term Workforce Plan and promises an updated version in late 2025. But systems are being asked to act now, without clarity on who will deliver the change.

As I’ve repeatedly stated, the NHS can have as many plans as it wants but without the workforce, none of it is deliverable.

Staff are already overstretched. Redistribution of roles from hospitals to the community sounds logical but without investment in both settings during the transition, we risk destabilising one without strengthening the other.

Is This Time Different? What Makes This Plan More Than Déjà Vu?

Many aspects of the plan echo ideas from past reforms, Practice Based Commissioning, Primary Care Homes, PCNs, Provider Collaboratives. So, what’s different now?

• The whole system is expected to reconfigure around place and neighbourhood.
• Integrated Health Organisations (IHOs) may hold full budgets for local populations.
• The tone is firmer. This plan doesn’t invite change, it assumes it.

But as I’ve said, without resources, deadlines or levers for accountability, ambition may not equal action.

Pharma, Medtech and Device Companies: How To Align With The Future NHS

This plan transforms your customer and your market.

Your success depends on answering:

• Can our offer be deployed at place and neighbourhood scale, not just in hospitals?
• Do we align with priorities like prevention, population health and digital enablement?
• Are we engaging with NHS partners not just to sell, but to co-deliver transformation?
• Do we have the evidence, training support and pathways to support rapid, integrated adoption?

In my book Embedded, due for publication in September 2025, I explore exactly these questions. How do suppliers become strategic partners, not transactional vendors? How do you build the long game, not chase short term share?

This plan is the clearest signal yet that the long game is the only game and I’m here to help you play, and win.

Final Word: Vision Demands More Than Just Ambition

A map needs more than ambition.

The NHS 10-Year Plan offers clarity of direction, depth of thinking and breadth of ambition. But it’s dropping into a system which is exhausted and underfunded.

If it’s to succeed, the NHS needs investment, clear timelines and levers for accountability, a real plan for primary care, including dentistry and a workforce strategy that matches pace with reality.

Perhaps most importantly, it needs the courage to co-design with the people expected to deliver it, not impose from above.

I’ll continue to advise my NHS and industry clients on what this plan means in practice. But the core message remains the same, please don’t wait for certainty, start preparing now. The future NHS is being built. The question is, will you be part of it, or left behind by it?

Scott McKenzie Consultancy – Bridging the Gap Between NHS Systems and Suppliers

At www.scottmckenzieconsultancy.com, we work directly inside the NHS, supporting provider organisations, commissioners and system leaders to implement real change. We then help pharma, medtech, and device companies interpret what’s happening, so they can engage the right stakeholders, align with NHS priorities and get their innovations embedded into care pathways.

With 10 years in pharma and more than 20 years working within the NHS, Scott brings a unique dual perspective, now captured in his upcoming book, launching September 2025, Embedded: How Pharma, MedTech and Device Companies Can Get Their Products into NHS Pathways and Stay There. It distils everything he’s learned into a practical playbook. Whether you’re launching a new product or trying to unlock stalled adoption, this book will show you how to reframe your offer, align with NHS priorities and make change stick.

You can read more about it here.